The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
about
The pharmacokinetics of perindopril in patients with liver cirrhosisImpact of disease states on the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors.Acute effect of an alpha 1-adrenoceptor antagonist on urinary sodium excretion, plasma atrial natriuretic peptide, arginine vasopressin, and the renin-aldosterone system in healthy subjects.
P2860
The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
@en
The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
@nl
type
label
The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
@en
The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
@nl
prefLabel
The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
@en
The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
@nl
P2093
P2860
P1476
The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1990.TB03700.X
P407
P577
1990-06-01T00:00:00Z